LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-07-01
|
| Series: | Lupus Science and Medicine |
| _version_ | 1797693083316387840 |
|---|---|
| author | Dipti Thakkar Konrad Paszkiewicz Shalini Paliwal Piers Ingram Jerome Boyd-Kirkup Wen Jie Chin Warren Lee Jie Ying Jacklyn Neo Brendon Hanson |
| author_facet | Dipti Thakkar Konrad Paszkiewicz Shalini Paliwal Piers Ingram Jerome Boyd-Kirkup Wen Jie Chin Warren Lee Jie Ying Jacklyn Neo Brendon Hanson |
| author_sort | Dipti Thakkar |
| collection | DOAJ |
| first_indexed | 2024-03-12T02:37:25Z |
| format | Article |
| id | doaj.art-91030b20ed314f0bba504560bd9c3950 |
| institution | Directory Open Access Journal |
| issn | 2053-8790 |
| language | English |
| last_indexed | 2024-03-12T02:37:25Z |
| publishDate | 2023-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Lupus Science and Medicine |
| spelling | doaj.art-91030b20ed314f0bba504560bd9c39502023-09-04T11:35:08ZengBMJ Publishing GroupLupus Science and Medicine2053-87902023-07-0110Suppl 110.1136/lupus-2023-KCR.48LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disordersDipti Thakkar0Konrad Paszkiewicz1Shalini Paliwal2Piers Ingram3Jerome Boyd-Kirkup4Wen Jie Chin5Warren Lee6Jie Ying Jacklyn Neo7Brendon Hanson8Research, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, SingaporeResearch, Hummingbird Bioscience, Singapore |
| spellingShingle | Dipti Thakkar Konrad Paszkiewicz Shalini Paliwal Piers Ingram Jerome Boyd-Kirkup Wen Jie Chin Warren Lee Jie Ying Jacklyn Neo Brendon Hanson LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders Lupus Science and Medicine |
| title | LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders |
| title_full | LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders |
| title_fullStr | LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders |
| title_full_unstemmed | LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders |
| title_short | LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders |
| title_sort | lso 006 targeting pathogenic auto reactive vh4 34 b cells with a rationally developed and highly specific anti vh4 34 antibody offers a new therapeutic approach for vh4 34 autoimmune disorders |
| work_keys_str_mv | AT diptithakkar lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT konradpaszkiewicz lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT shalinipaliwal lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT piersingram lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT jeromeboydkirkup lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT wenjiechin lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT warrenlee lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT jieyingjacklynneo lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders AT brendonhanson lso006targetingpathogenicautoreactivevh434bcellswitharationallydevelopedandhighlyspecificantivh434antibodyoffersanewtherapeuticapproachforvh434autoimmunedisorders |